Hub of Eco-Friendly IT-Biotech Convergence Industry

The CBFEZ is located at the center of Korea, which allows fast access to inland regions and a transportation network that runs in all directions. It is Korea’s IT-biotechnology convergence industry hub, equipped with a cluster of facilities for solar energy generation, semiconductor manufacturing and biotechnology businesses. It is also turning itself into the hub of Northeast Asia’s aviation Maintenance, Repair and Operations (MRO) industry.

• Designation Date2013.2.14
• Development period2013 to 2024

Center of Korea’s transportation

• The zone has access to the Seoul metropolitan area in one hour, and other parts of the nation in two hours.
• Seven high ways pass through the zone. Osong Station, the only station where the Gyeongbu Line intersects with the Honam Line, connects all parts of the country.
• Cheongju International Airport, the hub of the central region, is nearby.
• Cheongju International is the only local airport that runs 24 hours for freight air carriers.
• The CBFEZ has access to major Asian countries such as China and Thailand within one to three hours.
• It takes 10 minutes to get to Sejong City, the new administrative capital of Korea, and one hour to get to Pyeongtaek and Dangjin port, the center of marine logistics from the zone.

Korea’s only bio hub with one-stop support for all industrial process

• “Osong Bio-Health Science Complex” is Korea’s only biotech complex initiated by the government. “Osong HighTech Medical Complex” has ideal human resources and infrastructure to develop new medicines and advanced medical devices. This zone also has a biomedical administration town where six state-run institutions in health and medical services, such as the Ministry of Food and Drug Safety, are located.
• It has four major government research facilities and national biomedical facilities.
• It can offer one-stop support for all stages of bio manufacturing, from clinical trials to approvals to manufacturing and retailing. It is home to more than 60 biomedical companies, 120 bio-related company-affiliated research centers and three universities specialized in biotechnology.